Similarly, the ablation of oncogenic drivers, such as KRASG12D or cMyc, produced compensatory autocrine upregulation of IGFR-AKT pathway that was interpreted as crucial for resistance of dormant cancer cells and recurrence39. The gene discussed is MYC; the disease is cancer.